Cancer BiologyNature CommunicationsPeer-reviewed
Patient-derived xenografts and organoids model therapy response in prostate cancer
S. Karkampouna, F. La Manna, M. R. De Filippo…·M. Kruithof-de Julio
This study develops a patient-derived xenograft (PDX) model of prostate cancer that mimics disease stages and identifies drug sensitivities in metastatic cases.
DOI 10.1038/s41467-021-21300-6